Mark Tepper
2017
In 2017, Mark Tepper earned a total compensation of $1.3M as President and Chief Scientific Officer at Corbus Pharmaceuticals Holdings, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $164,903 |
|---|---|
| Option Awards | $765,210 |
| Salary | $349,000 |
| Total | $1,279,113 |
Tepper received $765.2K in option awards, accounting for 60% of the total pay in 2017.
Tepper also received $164.9K in bonus and $349K in salary.
Rankings
In 2017, Mark Tepper's compensation ranked 7,796th out of 14,666 executives tracked by ExecPay. In other words, Tepper earned more than 46.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,796 out of 14,666 | 47th |
Division Manufacturing | 2,922 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 951 out of 2,075 | 54th |
Industry group Drugs | 738 out of 1,731 | 57th |
Industry Pharmaceutical Preparations | 577 out of 1,333 | 57th |
Source: SEC filing on April 13, 2018.
Tepper's colleagues
We found three more compensation records of executives who worked with Mark Tepper at Corbus Pharmaceuticals Holdings in 2017.